ROADSHOW PRESENTATION JANUARY 2020 1 NOVEMBER 2019 DNA AK K A G - - PowerPoint PPT Presentation

NOVEMBER 2019

1

ROADSHOW PRESENTATION

JANUARY 2020

2

DNA

AK K A G ROUP

3

JANUARY 2020

Q3 2019 H1 2019 DNA DATA RESPONS

1,505 M€

2018 Group revenue Up 12.8% YOY*

>20,000

Skilled Employees Up 35.5% YOY

25

Countries

EU LEADER

Digital & Engineering In Mobility

9.5%

Revenue Organic Growth in FY 2018

* PDS Tech is consolidated as of 1st November 2018

GROUP OVERVIEW 2018

4

JANUARY 2020

Q3 2019 H1 2019 DNA DATA RESPONS

THE MAKING OF A EUROPEAN LEADER

Creating AKKA in the automotive sector in France

1984

Reaching

€40M

revenue accelerating diversificatio n in aerospace

1999

INITIAL PUBLIC OFFERING

aeronautics become the main segment

2005

40%

Revenue generated

• utside of

France

2012

AKKA reaches

€1BILLION

in revenue

2015

Becoming a leader in Germany

60%

revenue generated

• utside
• f France

2017

Enhanced diversificatio n in aerospace in the US

2018 2020

Acceleration in DIGITAL with DATA

RESPONS

5

JANUARY 2020

Q3 2019 H1 2019 DNA DATA RESPONS

THE MAKING OF A EUROPEAN LEADER

Creating AKKA in the automotive sector in France

1984

Reaching

€40M

revenue accelerating diversification in aerospace

1999 INITIAL PUBLIC OFFERING

aeronautics become the main segment

2005

40%

Revenue generated

• utside of

France

2012

AKKA reaches

€1BILLION

in revenue

2015

Becoming a leader in Germany

60%

revenue generated

• utside
• f France

2017

Enhanced diversification in aerospace in the US

2018 2020

6

JANUARY 2020

Q3 2019 H1 2019 DNA DATA RESPONS

AKKA TECHNOLOGIES RANKS AMONG THE TOP 5 EUROPEAN PLAYERS IN ENGINEERING CONSULTING

OUR STRENGTHS OUR OFFER OUR CLIENTS/PARTNERS

Largest European OEMs and industrial companies. Support clients in the conception of new products:

• ver entire product design cycle

and the value chain

• in

their international expansion, globalisation and digitalisation

• Boost
• ur

client’s performance through innovation, increased value added, agility & cross-sector expertise.

• Tailored

transnational turnkey projects.

• Through 21 skills centres
• Thanks to 20,000 dedicated

experts worldwide

7

JANUARY 2020

Q3 2019 H1 2019 DNA DATA RESPONS

STRATEGY OF BALANCES

DELIVERING RESULTS SINCE 1999

GEOGRAPHICAL BALANCE CLIENT BALANCE FINANCIAL BALANCE SKILLS BALANCE

8

JANUARY 2020

Q3 2019 H1 2019 DNA DATA RESPONS

Design

• ffice/

process

1984

Design, powertrain, vehicle architecture Embedded IT (Coframi) ADAS/ Link & Go Downstream aerospace (Aeroconseil)

1995 2006 2007 2009 2011

Mechatronic, electric & hybrids

2012 2015

IoT Digital

2015 2019

BALANCING OUR SKILL-SETS AND ANTICIPATING DISRUPTIVE TECHNOLOGIES

9

JANUARY 2020

Q3 2019 H1 2019 DNA DATA RESPONS

Mobility

82%

Automotive 37% Aerospace 34% Suppliers 8% Railways 3%

Energy 4% Life sciences 6% Others 8%

€ 1.7Bn AKKA 2018 pro forma € 1.7Bn

Intl

18%

France

37%

Germany

29%

North America

16%

10

JANUARY 2020

Q3 2019 H1 2019 DNA DATA RESPONS

STRONG CLIENT DIVERSIFICATION

11

JANUARY 2020

Q3 2019 H1 2019 DNA DATA RESPONS

COMBINED ACQUISITIONS & ORGANIC GROWTH

AKKA:

+22%

VS SECTOR:

+9%

CAGR 2006-2018*

* Pro forma including PDS Tech

2006 2011 2015 2017 2018

REVENUE (€M)

€1.0B €0.5B €1.3B €1.7B* €0.15B

12

JANUARY 2020

Q3 2019 H1 2019 DNA DATA RESPONS

160 236 382 333 400 474 827 879 886 1,002 1,123 1,334 1,505

FY06 FY07 FY08* FY09 FY10 FY11 FY12 FY13 FY14 FY15 FY16 FY17 FY18**

Revenues in €M

PROFITABLE GROWTH

* Pro forma before the 2009 divestment ** PDS Tech is consolidated as of 1st November 2018

EBITDA % of Sales 2006 - 2018

Average : 8.7% Always > 7%

Leverage Ratio 2006 - 2018

Average : 1.0x Highest : 2.0x

13

JANUARY 2020

Q3 2019 H1 2019 DNA DATA RESPONS

SMART CONNECTED SOLUTIONS UNIQUE VISION ON THE INDUSTRY A UNIQUE EDGE ON DIGITAL TECHNOLOGIES STRONG TRACK RECORD IN INTEGRATING ACQUSITIONS CAPACITY TO ANTICIPATE DISRUPTIVE TECHNOLOGY CAPACITY TO DELIVER LARGE TRANSNATIONAL PROJECTS

CONSULTING ENGINEERING

21 SKILL CENTRES DELIVERING TURNKEY SOLUTIONS

UNIQUELY POSITIONED TO DESIGN TOMORROW’S PRODUCTS

14

PROPOSED ACQUISITION OF DATA RESPONS

CRE ATI NG A UN I QUE DI G I TAL LE ADE R

15

JANUARY 2020

Q3 2019 H1 2019 DNA DATA RESPONS

CLEAR 2022

CUSTOMER- ORIENTED

C

Top 20 clients above €50M revenue*

LEADERSHIP IN INNOVATION

L

75% of our activities in the digital field

EXCELLENCE IN DELIVERY

E

Increase projects gross margin by 2%

ATTRACTIVE FOR TALENTS

A

Hire 10,000 talented digital natives

RESULTS- ORIENTED

R

Commited to best-in-class performance

*On average

16

JANUARY 2020

Q3 2019 H1 2019 DNA DATA RESPONS

A GAME CHANGER

Perfect strategic fit Strong value creation

A SCALABLE DIGITAL INNOVATION POWERHOUSE

17

JANUARY 2020

Q3 2019 H1 2019 DNA DATA RESPONS

A COMBINED EXPERTISE IN ENGINEERING & DIGITAL

SERVICE & AFTER SALES DIGITAL MANUFACTURING CONNECTED PRODUCTS DIGITAL ENGINEERING

IOT, AI & ROBOTICS ANALYTICS DIGITAL WORKER PRODUCT IV&V

Cybersecurity

18

JANUARY 2020

Q3 2019 H1 2019 DNA DATA RESPONS

SMART CONNECTED SOLUTIONS IMMERSIVE TECHNOLOGIES DIGITAL APPLICATIONS DESIGN SYSTEMS SECURITY DATA INTELLINGENCE SHOPFLOOR SOLUTIONS

CONSULTING ENGINEERING

MANUFACTURING

A GAME CHANGER

19

JANUARY 2020

Q3 2019 H1 2019 DNA DATA RESPONS

€ 0.9Bn € 1.3Bn €1.7Bn

1

€ 2.5Bn

CLEAR 2022 2014 2017 2018 2022

CLEAR 2022: LAUNCH OF PHASE II

GROWTH ACCELERATORS

Automotive Aerospace Digital

* AKKA Proforma figures including PDS Tech

2020

20

DATA RESPONS

JANUARY 2020

DNA OPPORTUNITIES FINANCE CLEAR 2022

21

A complete technology partner

for smarter embedded and IoT solutions

• Digitalisation of the industries of tomorrow!

Connectivity IoT / Digitalisation Software & APPs Security Embedded Solutions R&D Services AI / Analytics Sensor Mobile services Electrification Cloud

JANUARY 2020

OPPORTUNITIES FINANCE CLEAR 2022

22

REVENUE

17%

annual growth

2000-2018

• 100

100 300 500 700 900 1,100 1,300 1,500 00 01 02 03 04 05 06 07 08 09 10 11 12 13 14 15 16 17 18

SUCCESFULL & PROFITABLE GROWTH

16x

2000-2018

JANUARY 2020

OPPORTUNITIES FINANCE CLEAR 2022

23

LOCATIONS

NORWAY

5

LOCATIONS

DENMARK

2

LOCATIONS

GERMANY

7

LOCATIONS

SWEDEN

3

Our companies:

AT A GLANCE

NOK I.5 billion 1 400 specialists >1 000s R&D projects 40 nationalities

TAIWAN

JANUARY 2020

24

All numbers are YTD figures

DIVERSIFIED CUSTOMER PORTFOLIO

ENERGY & MARITIME 11% MOBILITY 36% TELECOM & MEDIA 18% SPACE, DEFENCE & SECURIY 10% INDUSTRY & AUTOMATION 14% OTHER 1% MEDTECH 7% FINANCE & PUBLIC 4%

STRONG DIVERSIFICATION

across several industries

A CUSTOMER & TECHNOLOGY DRIVEN ORGANISATION

Building long-term customer relationships based on strong industry know-how, niche competence and local touch

18% 26% 40% Top 3 customers Top 10 customers Top 5 customers

25

JANUARY 2020

Q3 2019 H1 2019 DNA DATA RESPONS

• R&D - Product

development

• Business critical
• Long-term R&D projects
• Strategically important
• Domain COMPETENCE

& industry knowhow

Data driven DEVELOPMENT support Contract in Germany of NOK 225 million Smart INFRASTRUCTURE for IoT applications Contract in Sweden of SEK 40 million MEDTECH solutions Frame agrmt. in Norway of NOK 40 million p.a. Smart FACTORY Contract in Germany of NOK 13 million Advanced COMMUNICATION solution Contract in Norway of NOK 18 million

MAJOR CONTRACT EXAMPLES

JANUARY 2020

DNA OPPORTUNITIES FINANCE CLEAR 2022

26

THE MOTHER OF ALL TECH BATTLES

ELECTRIFICATION CONNECTIVITY SHARED MOBILITY AUTONOMOUS DRIVING

Source: GP Bullhound

JANUARY 2020

DNA OPPORTUNITIES FINANCE CLEAR 2022

27

IoT

In-vehicle infotainment system Embedded software Autonomous driving Sensors SW frameworks AI/analytics New telematics solutions Connectivity remote SW update Security Condition monitoring Fleet management systems Testing Digitalisation of the product development cycle Car sharing User based insurance Car-as-a-service

CARS ARE BECOMING COMPUTERS ON WHEELS

APPS AND SERVICES DATA ANALYTICS ENTERTAINMENT PLATFORM AUTONOMOUS DRIVE/OPERATING SYSTEM

28

Q3 2019 H1 2019 DNA DATA RESPONS

JANUARY 2020

Source: Deloitte 2019 Global Automotive Supplier Study | Slide 28

POSITIONED IN ATTRACTIVE SEGMENTS

Data Respons is involved in several projects across all growth segments

Fleet Management systems In-vehicle infotainment systems New telematics solutions Car sharing applications Electric and hybrid drivetrain technology Connectivity and remote SW update solutions Autonomous driving projects (ADAS) Car-as-a-service projects

JANUARY 2020

DNA OPPORTUNITIES FINANCE CLEAR 2022

29

EVERYTHING DIGITALISED, CONNECTED, AUTOMATED EVERYWHERE

30

A NEW DIGITAL LEADER

WITH STRONG VALUE CREATION

31

JANUARY 2020

Q3 2019 H1 2019 DNA DATA RESPONS

A POWERFUL €2BN PLATFORM FOR A DATA-DRIVEN WORLD

25 countries Revenues c. EUR 2BN > 22,000 experts

Combined figures

32

JANUARY 2020

Q3 2019 H1 2019 DNA DATA RESPONS

GROWTH 2016-18 CAGR REVENUE OF WHICH: ORGANIC1

7% 16% 20% 12%

A DRIVER TO ACCELERATE PROFITABLE GROWTH

EBITA2

24% 42%

33

JANUARY 2020

Q3 2019 H1 2019 DNA DATA RESPONS

2019E ORGANIC GROWTH EBITA MARGIN

8.0% 6% >10% 11.9%

Source: Factset consensus

AN ACCRETIVE TRANSACTION

NET INCOME MARGIN

4.3% 7.9%

→ Estimated EPS accretion > 20%1

34

JANUARY 2020

Q3 2019 H1 2019 DNA DATA RESPONS

• c. EUR200M additional REVENUE and
• c. EUR25M additional EBITA

expected yearly by end 2022 Deploying AKKA

• ffering in Nordics

Platform for attracting more digital talents Boosting digital activities in countries with high-demand Capacity on federating other niche players Opening new doors for Data Respons Leverage Data Respons’ software expertise

STRONG COMMERCIAL SYNERGIES

35

JANUARY 2020

Q3 2019 H1 2019 DNA DATA RESPONS

• Transaction recommended unanimously by both Boards of Directors
• Irrevocables totalling c.43% of the register, including the key shareholders

Key support & commitments

• AKKA to launch a voluntary tender offer with support from Data Respons’ Board of Directors on or

around 13th January 2020

• NOK 48 per share in cash representing a clear premium (as of 18 Dec 2019) of:

▪ 20% over spot price ▪ 29% over last 3 month VWAP ▪ 34% over last 6 months VWAP

• Corresponds to equity value of NOK 3.7BN / € 366M1
• Offer subject to customary regulatory approval in Germany and 90% acceptance rate from Data

Respons shareholders

• Committed financing in place via existing credit facilities to fund 100% of the purchase price
• Ample financial headroom & liquidity post acquisition

Key transaction terms Financing

KEY TRANSACTION TERMS

1 As of 18 Dec, 2019 - NOK/EUR of 0.09962 exchange rate

36

JANUARY 2020

Q3 2019 H1 2019 DNA DATA RESPONS

ENVISAGED TRANSACTION TIMELINE

December 19th Announcement Board recommendation Offer document approval period Mid-Jan Tender offer launched Closing of transaction expected by Q1 2020 Mid-Feb Tender offer results announced January December February March

37

Q3 2019

HI G HLI G HTS

38

Q3 2019 H1 2019 DNA DATA RESPONS

JANUARY 2020

STRONG PERFORMANCE IN Q3 2019

€441.1M

* Pro-forma growth

€123.5M €75.9M €78.4M

NORTH AMERICA

€163.3M

FRANCE

STRONG PERFORMANCE IN Q3 2019

* Pro-forma growth

+7.4%*

GROUP

+7.8%*

INTERNATIONAL

+2.4%*

GERMANY

+16.8%*

NORTH AMERICA FRANCE

+7.0%*

39

Q3 2019 H1 2019 DNA DATA RESPONS

JANUARY 2020

STRONG PERFORMANCE IN YTD 9M 2019

€1,332.5M

GROUP

+8.0%*

* Pro-forma growth

€378.9M +1.7%*

GERMANY

€228.7M +6.7%*

INTERNATIONAL

€230.8M +22.7%*

NORTH AMERICA

€494.1M

FRANCE

+7.7%*

40

Q3 2019 H1 2019 DNA DATA RESPONS

JANUARY 2020

Q3 2019: REVENUE BY BU

€M Q3 2019 REVENUE Q3 2018 REVENUE % CHANGE ORGANIC PRO FORMA

FRANCE 163.3 152.6 7.0% 7.0% 7.0% GERMANY 123.5 120.6 2.4% 2.4% 2.4% NORTH AMERICA 78.4 6.1 1,186.6% 35.1% 16.8% INTERNATIONAL 75.9 70.4 7.8% 6.9% 7.8%

TOTAL GROUP 441.1 349.8 26.1% 5.9% 7.4%

41

Q3 2019 H1 2019 DNA DATA RESPONS

JANUARY 2020

YTD 9M 2019: REVENUE BY BU

€M YTD 9M 2019 REVENUE YTD 9M 2018 REVENUE % CHANGE ORGANIC PRO FORMA

FRANCE 494.1 458.7 7.7% 7.7% 7.7% GERMANY 378.9 372.6 1.7% 1.7% 1.7% NORTH AMERICA 230.8 16.2 1,327.4% 43.3% 22.7% INTERNATIONAL 228.7 214.2 6.7% 6.2% 6.7%

TOTAL GROUP 1,332.5 1,061.7 25.5% 5.9% 8.0%

42

Q3 2019 H1 2019 DNA DATA RESPONS

JANUARY 2020

YTD 9M 2019: A WELL BALANCED REVENUE STREAM

+5.9%

TOTAL GROUP ORGANIC GROWTH France +7.7% Germany +1.7% North America +43.3% International +6.2% YTD 9M 2019

€ 1,332.5M

Intl

17%

France

37%

Germany

28%

North America

18%

43

Q3 2019 H1 2019 DNA DATA RESPONS

JANUARY 2020

Mobility

80%

Automotive 33% Aerospace 31% Suppliers 12% Railways 4%

Energy 4% Chemistry and health 5% Others 11%

YTD 9M 2019

€ 1,332.5M

ORGANIC GROWTH (YTD 9M 2019)

Auto

+6%

Aero

+10%

Railways

+17%

YTD 9M 2019: STRONG DIVERSIFICATION

44

FINANCIAL RESULTS

H1 2 0 1 9

45

JANUARY 2020

Q3 2019 H1 2019 DNA DATA RESPONS

H1 2019: VERY STRONG PERFORMANCE

€891.4M

H1 2019 REVENUE

+25% YoY

€60.0M

OPERATING PROFIT

+23% YoY

EPS

€1.31

+38% YoY

46

JANUARY 2020

Q3 2019 H1 2019 DNA DATA RESPONS

BPS

+40

at 7.3%

GROUP OPERATING MARGIN Excl. PDS:

H1 2019: PROFIT FROM BUSINESS OPERATIONS

France Germany North America Intl H1 2018 H1 2019

At 7.7%

+40 BPS

At 10.5%*

+50 BPS

At 11.1%

+40 BPS

At 3.6%

+250 BPS

* Incl. CIR

47

JANUARY 2020

Q3 2019 H1 2019 DNA DATA RESPONS

BECOMING A LEADER IN NORTH AMERICA STRONG INCREASE OF PDS TECH PROFITABILITY

€161M

PDS TECH H1 2019 REVENUE

23%

PDS TECH REVENUE GROWTH PDS TECH H1 2019 OPERATING MARGIN

3.6%

48

JANUARY 2020

Q3 2019 H1 2019 DNA DATA RESPONS

AKKA IN H1 2019: NET INCOME UP +41%

€M H1 2019 H1 2018 % CHANGE

REVENUE 891.4 711.9 25.2% PROFIT FROM ORDINARY ACTIVITIES 59.2 48.8 21.3% IFRS 16 Impact 0.8 PROFIT FROM ORDINARY ACTIVITIES (Incl. IFRS 16) 60.0 48.8 22.9% % REVENUE 6.7% 6.9%

• 20 bps

OTHER NON-RECURRING (11.5) (8.0) FREE SHARES, STOCK OPTIONS (3.4) (3.7) OPERATING INCOME 45.1 37.1 21.6% % REVENUE 5.1% 5.2%

• 10 bps

FINANCIAL RESULT (8.2) (9.4) PRE-TAX INCOME 61.9 27.7 33.5% TAX EXPENSE (10.6) (7.1) CONSOLIDATED NET INCOME 26.3 20.6 27.8% MINORITY INTEREST (0.04) (1.9) GROUP NET INCOME 26.3 18.7 40.8% EPS 1.31 0.95 38.2%

49

JANUARY 2020

Q3 2019 H1 2019 DNA DATA RESPONS

H1 2019: HEALTHY BALANCE SHEET x2.3

LEVERAGE

Assets Liabilities

In €M H1 2019 H1 2018

GOODWILL 611.3 286.1 INTANGIBLE ASSETS 20.4 19.4 PROPERTY, PLANT & EQUIPMENT 93.7 89.6 Right of use/ IFRS16 155.7 OTHER NON CURRENT ASSETS 156.1 153.1 NON-CURRENT ASSETS 787.3 548.2 INVENTORIES 9.3 8.3 RECEIVABLES 397.2 371.0 CASH AND CASH EQUIVALENTS 187.3 278.2 CURRENT ASSETS 593.8 657.5 TOTAL ASSETS 1,381.1 1,205.7

In €M H1 2019 H1 2018

GROUP SHARE OF EQUITY 267.8 237.1 NON-CONTROLLING INTERESTS 0.4 61.3 SHAREHOLDERS’ EQUITY 268.2 273.4 NON-CURRENT LIABILITIES 644.6 544.3 CURRENT PROVISIONS 2.9 4.5 OTHER CURRENT FINANCIAL LIABILITIES 83.5 7.7 CURRENT LEASE LIABILITIES/IFRS16 28.8 OTHER CURRENT LIABILITIES 353.1 375.8 CURRENT LIABILITIES 468.3 388.0 TOTAL LIABILITIES 1,381.1 1,205.7

50

JANUARY 2020

Q3 2019 H1 2019 DNA DATA RESPONS

NET DEBT 30th JUNE 2019 + ODIRNANE

179.8 M€

NET DEBT (€M)

41%

GEARING

CP 5% SSD 93%

DEBT PROFILE (%) AS OF 30/06/2019

RCF: €545M (not drawn as of 23/12/2019) NEU CP ISSUE: €240M potential unused DEBT CHARACTERISTICS:

• Average maturity of 3 years
• Average cost of debt: 1.4%
• Leverage pos ODIRNANE:

1.15x *

• Gearing post ODIRNANE:

41% *

52 7.5

317.5 127.5

5 200 11.4 25 2019 2021 2022 2023 2024 2027 SSD UNDRAWN RCF PDS RCF CP

*without IFRS16

51

JANUARY 2020

Q3 2019 H1 2019 DNA DATA RESPONS

NET DEBT SEASONALITY (€M)

30 76 46 109 94 141 97 223 195 244 279 369

FY 13 H1 14 FY 14 H1 15 FY 15 H1 16 FY 16 H1 17 FY 17 H1 18 FY 18 H1 19

52

JANUARY 2020

Q3 2019 H1 2019 DNA DATA RESPONS

PAST 12 MONTHS: EVOLUTION OF NET CASH POSITION (€M)

278.2 187.3 125.7 (32.7) (14.9) (25.6) (119.5) (13.8) 12.8 (22.9)

NET CASH 30/06/18 CASH FLOW CHANGE IN WORKING CAPITAL TAXES CAPEX ACQUISITIONS & CHANGE IN SCOPE DIVIDENDS FINANCING ACTIVITIES FINANCIAL INTERESTS & OTHER NET CASH 30/06/19

53

JANUARY 2020

Q3 2019 H1 2019 DNA DATA RESPONS

FINANCING CAPACITY

€907M

GROSS CASH 30/06/2019

€187M

CF*

€545M

+

* Credit Facility

+

ODIRNANE

€175M

PAVING THE WAY TO CLEAR 2022: STRONG CAPACITY TO FUEL GROWTH

54

JANUARY 2020

Q3 2019 H1 2019 DNA DATA RESPONS

2019 TARGETS CONFIRMED

0% 10%

Organic growth

≥ 6%

Operating margin

≥ 8%

Free cash flow generation

≥ 5%

55

THANK YOU!

Q&A SESSION

56

JANUARY 2020

57

JANUARY 2020

CONTACT

akka-technologies.com

akka-technologies @akka_tech AKKATechnologies1

58

JANUARY 2020

DISCLAIMER

• This presentation does not contain or constitute an offer of securities for sale or an invitation or inducement to invest

in securities in France, the United States or any other jurisdiction.

• This presentation may contain information expressed as forward-looking statements. Forward-looking statements are

statements that are not historical facts. Forward-looking statements may include anticipations, projections and their underlying assumptions as well as statements (regarding plans, objectives, expectations and intentions, future financial results, potential events, operations, services, products). Such information concerns either trends or targets and cannot be regarded as results forecasts or as any other performance indicator.

• This information is by nature subject to risk and uncertainty, that may cause the actual results to differ from those

mentioned in the forward-looking statements. Even though AKKA Group’s management believes that the expectations reflected as of the date of this presentation in such forward-looking statements are reasonable, this information does not reflect the Group's future performance and is not intended to give any assurances or comfort as to future results. Therefore no-one should unduly rely on these forward-looking statements. The AKKA Group makes no commitment to update this information.

• More comprehensive information on the AKKA Technologies Group may be obtained on our website.

59

APPENDICES

60

Q3 2019 H1 2019 DNA DATA RESPONS

JANUARY 2020

H1 2019: REVENUE BY BU

€M H1 2019 REVENUE H1 2018 REVENUE % CHANGE ORGANIC PRO FORMA

FRANCE 330.8 306.0 8.1% 8.1% 8.1% GERMANY 255.4 252.0 1.4% 1.4% 1.4% NORTH AMERICA 152.4 10.1 1,412.5% 48.2% 26.1% INTERNATIONAL 152.8 143.8 6.2% 5.8% 6.2%

TOTAL GROUP 891.4 711.9 25.2% 5.9% 8.3%

61

Q3 2019 H1 2019 DNA DATA RESPONS

JANUARY 2020

REVENUE BY QUARTER (€M)

268.3 281.8 272.9 299.5 328.3 338.2 310.3 357.6 353.9 358.0 349.8 443.7 446.3 445.2 441.1

Q1 16 Q2 16 Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19

+26.1%

62

Q3 2019 H1 2019 DNA DATA RESPONS

JANUARY 2020

H1 2019: PROFIT FROM BUSINESS OPERATIONS

H1 2019 H1 2018 €M % of revenue €M % of revenue Growth FRANCE 24.9 7.5% 21.9 7.2% 12.3% GERMANY 19.7 7.7% 18.5 7.3% 4.3% NORTH AMERICA 5.6 3.6% 0.1 1.1% 5,400% INTERNATIONAL 17,0 11.1% 15.4 10.7% 9.7% OTHER (7.1) (7.1)

TOTAL GROUP 60.0 6.7% 48.8 6.9% 23.0%

63

Q3 2019 H1 2019 DNA DATA RESPONS

JANUARY 2020

H1 2019: IFRS 16 impact

IN €M H1 2019 (W/O IFRS 16) IFRS 16 IMPACT H1 2019 (IFRS 16)

EBIT 59.2 6.6% 0.8 60.0 6.7% EBITDA 69.4 7.8% 16.3 85.7 9.6% FINANCIAL RESULT

• 6.5
• 1.7
• 8.2

NET RESULT 27.1 3.0%

• 0.8

26.3 2.9% NET DEBT 618.9 41.4% 157.4 526.3 59.0% LEVERAGE 2.26x 2.96x COVENANT <3.5x <4.5x

64

Q3 2019 H1 2019 DNA DATA RESPONS

JANUARY 2020

H1 2019: HEALTHY BALANCE SHEET

In €M H1 2019 H1 2018

GOODWILL 611.3 286.1 INTANGIBLE ASSETS 20.4 19.4 PROPERTY, PLANT & EQUIPMENT 93.7 89.6 Right of use/ IFRS16 155.7 NON-CURRENT FINANCIAL ASSETS 38.8 35.8 AFFILIATED COMPANIES & JV 47.4 46.6 OTHER NET LONG-TERM ASSETS 35.1 61.4 DEFERRED TAX ASSETS 34.8 34.3 NON-CURRENT ASSETS 787.3 548.2 INVENTORIES 9.3 8.3 ACCOUNTS RECEIVABLE 302.6 254.8 OTHER RECEIVABLES 94.6 116.2 CASH AND CASH EQUIVALENTS 187.3 278.2 CURRENT ASSETS 593.8 657.5 TOTAL ASSETS 1,381,1 1,205.7

x2.3

LEVERAGE

In €M H1 2019 H1 2018

GROUP SHARE OF EQUITY 267.8 237.1 NON-CONTROLLING INTERESTS 0.4 61.3 SHAREHOLDERS’ EQUITY 268.2 273.4 NON-CURRENT ACCRUALS 28.7 26.0 OTHER NON-CURRENT LIABILITIES 487.2 518.3 NON-CURRENT LEASE LIABILITIES/IFRS16 128.7 NON-CURRENT LIABILITIES 644.6 544.3 CURRENT ACCRUALS 2.9 4.5 OTHER CURRENT FINANCIAL LIABILITIES 83.5 7.7 CURRENT LEASE LIABILITIES/IFRS16 28.8 TRADE PAYABLES 102.4 106.4 TAX AND SOCIAL SECURITY 203.4 222.6 OTHER LIABILITIES 47.3 46.8 CURRENT LIABILITIES 468.3 388.0 TOTAL LIABILITIES 1,381.1 1,205.7

Assets Liabilities

65

Q3 2019 H1 2019 DNA DATA RESPONS

JANUARY 2020

H1 2019: EVOLUTION OF NET CASH POSITION (€M)

271.8 187.3 58.9 (102.1) (9.0) (14.3) (14.2) 3.1 (6.9)

NET CASH 31/12/18 CASH FLOW CHANGE IN WORKING CAPITAL TAXES CAPEX ACQUISITIONS & CHANGE IN SCOPE FINANCING ACTIVITIES FINANCIAL INTERESTS & OTHER NET CASH 30/06/19

66

Q3 2019 H1 2019 DNA DATA RESPONS

JANUARY 2020

76 67 75 64 66 54 59 53 55 53 52

H1 2014 FY 2014 H1 2015 FY 2015 H1 2016 FY 2016 H1 2017 FY 2017 H1 2018 FY 2018 H1 2019

DSO (DAYS SALES OUTSTANDING)

67

Q3 2019 H1 2019 DNA DATA RESPONS

JANUARY 2020

FACTOR (DAYS OF REVENUE)

37 32 41 37 42 34 49 40 51 52

FY 2014 H1 2015 FY 2015 H1 2016 FY 2016 H1 2017 FY 2017 H1 2018 FY 2018 H1 2019

68

Q3 2019 H1 2019 DNA DATA RESPONS

JANUARY 2020

HEADCOUNT (END OF PERIOD)

12,133 13,055 15,180 17,144 20,901 14,913 15,180 15,515 16,288 16,619 17,144 21,019 20,904 20,624 20,901 Q1 16 Q2 16 Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19

+1.3%

69

Q3 2019 H1 2019 DNA DATA RESPONS

JANUARY 2020

TURNOVER RATE (YTD)

17.6% 17.9% 17.6% 17.1% 17.7% 18.0% 17.6% 17.2% 18.5% 19.3% 19.2% 20.1% 20.8% 23.3% 23.1%

Q1 16 Q2 16 Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18* Q1 19* Q2 19* Q3 19*

• 20 bps

* Excluding PDS Tech

70

Q3 2019 H1 2019 DNA DATA RESPONS

JANUARY 2020

UTILISATION RATE (YTD)

87.8% 88.9% 89.5% 89.6% 88.9% 89.6% 89.6% 89.7% 88.9% 89.7% 89.9% 89.6% 88.3% 89.1% 89.5%

Q1 16 Q2 16 Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18* Q1 19* Q2 19* Q3 19*

+40 BPS

* Excluding PDS Tech

71

Q3 2019 H1 2019 DNA DATA RESPONS

JANUARY 2020

GLOSSARY

Cash flow from

• perations

before tax and financing costs (EBITDA): operating profit adjusted for additions to depreciation and amortization. EPS (Earnings Per Share): group net income divided by weighted average number

• f

shares

• utstanding less treasury stocks.

Free cash flow: EBITDA +/- change in working capital – net financial charges and taxes paid –

• capex. Free cash flow generation is measured as %
• f total revenue.

Leverage: ratio of net consolidated financial debt to EBITDA. Net Debt: The aggregate

• f

cash and cash equivalents,

• verdrafts

and short-term bank borrowings, non-current and debt, and financial instruments. surplus cash/(net debt) does not include non-current and current lease obligations (IFRS 16 impact). Operating profit: profit form

• rdinary

activities calculated before non-recurring items and expenses relating to stock options and free shares. Operating margin: ratio of operating profit to revenue. Organic growth: Revenue growth at constant scope and exchange rates. Pro forma growth: revenue growth in North America at constant exchange rate and including PDS Tech H1-18 revenue in total H1-18 revenue. PDS Tech is consolidated as of 1st November 2018.

72